“…For the initial screen, we selected 14 solvents as shown in Table . The selection was based on environmental and health impact as outlined by the recent solvent selection guides − and compatibility with Pd(II)–NHC systems. − , As a crucial selection criterion, solvents should also be readily available to the end-users in both industrial and academic settings, while their removal from the postreaction mixtures should be facile. Neolyst CX31, [Pd(IPr)(cin)Cl], IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene, was selected as the Pd(II)–NHC catalyst for the initial screen because of its robustness, commercial availability, and the high activity in the amide cross-coupling. , DME has been included for comparison as a benchmark.…”